Literature DB >> 9812782

Studies on the relationship between urokinase plasminogen activator (uPA) and human sperm motility.

X Huang1, W Xia, C Xiong, D Xiao, J Shen, J Zhou.   

Abstract

To clarify the role of urokinase plasminogen activator (uPA) in the mechanisms of regulating sperm motility and the ability of fertilizing, we investigated the quantities and activities of uPA in human seminal plasma and on the membrane of spermatozoa. Semens were harvested from 22 infertile patients with asthenospermia and 20 healthy fertile men according to WHO standards. To quantify the membrane-bound uPA in the samples, polyclonal antibodies against human urokinase were employed by means of a sandwich ELISA. The uPA activities in seminal plasma and on the surface of spermatozoa were determined using A-garose-Fibrine-Plate method and the experiment of immunological identification with polyclonal antibodies against urokinase. In lysates of spermatozoa, significantly lower levels of uPA (23.1 +/- 7.35 mu/10(6) cells) and uPA activity (5.13 +/- 3.85 mu/10(6) cells) were found in patient group as compared to healthy fertile men exhibiting normospermia (29.89 +/- 9.40 mu/10(6) cells and 10.17 +/- 6.18 mu/10(6) cells). In seminal plasma, uPA activity in patient group (2134 +/- 1581.3 IU/L) was also found significantly lower than that of normal group (3365 +/- 1859.5 IU/L). Positive correlations were observed between sperm motility and uPA quantities (r = 0.48, P < 0.005), as well as with uPA activities (r = 0.45, P < 0.005). Thus, it is inferred that membrane associated uPA on human spermatozoa may be related directly to sperm motility and fertility.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9812782     DOI: 10.1007/bf02895622

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  7 in total

1.  Seminal plasma plasminogen activator and fertility.

Authors:  I R MacGregor; T B Hargreave; R A Elton
Journal:  Andrologia       Date:  1987 Jul-Aug       Impact factor: 2.775

2.  Two plasminogen activators, streptokinase and urokinase, stimulate human sperm motility.

Authors:  C Y Hong; B N Chiang; J J Huang; P Wu
Journal:  Andrologia       Date:  1985 Jul-Aug       Impact factor: 2.775

3.  Fibrinolytic parameters in spermatozoas and seminal plasma.

Authors:  U Maier; J C Kirchheimer; G Hienert; G Christ; B R Binder
Journal:  J Urol       Date:  1991-09       Impact factor: 7.450

4.  Increased plasminogen activator activity and plasminogen activator inhibition in spermatozoa and seminal plasma of the ram after serum gonadotrophin (PMSG) administration. Correlation with the increased level of testosterone in the blood.

Authors:  C Rekkas; S Belibasaki; I Taitzoglou; N Kokolis; A Smokovitis
Journal:  Andrologia       Date:  1991 Jul-Aug       Impact factor: 2.775

5.  A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.

Authors:  J D Vassalli; D Baccino; D Belin
Journal:  J Cell Biol       Date:  1985-01       Impact factor: 10.539

6.  Plasminogen activator and mouse spermatozoa: urokinase synthesis in the male genital tract and binding of the enzyme to the sperm cell surface.

Authors:  J Huarte; D Belin; D Bosco; A P Sappino; J D Vassalli
Journal:  J Cell Biol       Date:  1987-05       Impact factor: 10.539

7.  A study of proteases and protease-inhibitor complexes in biological fluids.

Authors:  A Granelli-Piperno; E Reich
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

  7 in total
  2 in total

1.  Urokinase-type plasminogen activator: a new target for male contraception?

Authors:  Ying Qin; Yan Han; Cheng-Liang Xiong; Hong-Gang Li; Lian Hu; Ling Zhang
Journal:  Asian J Androl       Date:  2015 Mar-Apr       Impact factor: 3.285

2.  Clinical Efficacy of Prodom-Assisted Urokinase in the Treatment of Male Infertility Caused by Impaired Semen Liquefaction.

Authors:  Kaiyi Mao; Zongping Chen; Mengzhi Li; Chengren Gou; Zidong Zhou; Yong Yan; Chao Chen; Tong Liu; Chenghong Zou; Yuhong Yao; Xu Li
Journal:  Biomed Res Int       Date:  2021-01-19       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.